GlassScriptPhysician profile
David Alan Kanagy
NPI 1114915964
$3,219.61
in general payments reported to CMS, 2019-2025
23 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $236 · 2021: $282 · 2022: $406 · 2023: $996 · 2024: $496 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,697 · Travel and Lodging: $193 · Education: $54.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.19 |
| Travel and Lodging | $192.66 |
| Education | $54.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $706.13 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $698.56 | 2021-2025 | Dupixent |
| Acclarent, INC | $523.45 | 2019-2023 | Acclarent Aera |
| Inspire Medical Systems, INC. | $425.67 | 2023-2024 | Inspire |
| Stryker Corporation | $133.81 | 2019-2022 | |
| Glaxosmithkline, LLC. | $112.81 | 2021-2024 | Nucala |
| Optinose US, INC. | $84.49 | 2022-2023 | |
| Phadia US INC. | $82.66 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $54.95 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $52.01 | 2019-2025 | Caldolor |
| Intersect Ent, INC. | $51.59 | 2019 | |
| Hologic Sales and Service, LLC | $48.62 | 2023 | Coolseal Generator |
| Smith+Nephew, INC. | $44.46 | 2020-2024 | Halo, Coblation |
| Merck Sharp & Dohme LLC | $44.03 | 2023-2024 | Keytruda |
| Medtronic, INC. | $30.76 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.48 | 2025 | Tezspire |
| Paratek Pharmaceuticals, INC. | $17.91 | 2025 | Xhance |
| Alk-Abello, INC | $16.66 | 2021 | |
| Integra Lifesciences Corporation | $16.39 | 2025 | Integra, Microfrance, Integra Duo |
| Medtronic USA, INC. | $13.91 | 2020 | |
| Amgen INC. | $13.77 | 2025 | Tezspire |
| Conmed Corporation | $13.44 | 2022 | |
| Ambu INC. | $13.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kanagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.